Ipca Laboratories informs about company updates

02 Jul 2020 Evaluate

Further to it letters dated 21st March, 2020 and 24th June, 2020, Ipca Laboratories has informed that the US FDA through its e-mail dated 1st July, 2020 has intimated the Company that the shortage implications for Hydroxychloroquine Sulphate has changed and that it has been removed from list of drug products in shortage and therefore, the US FDA is removing the exemption given to us from the import alert for API and formulation of Hydroxychloroquine Sulphate.

The above information is a part of company’s filings submitted to BSE. 

Ipca Laboratories Share Price

1459.30 2.15 (0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×